Literature DB >> 7773930

Localization of oncofetal and normal fibronectin in colorectal cancer. Correlation with histologic grade, liver metastasis, and prognosis.

H Inufusa1, M Nakamura, T Adachi, Y Nakatani, K Shindo, M Yasutomi, H Matsuura.   

Abstract

BACKGROUND: Expression of oncofetal fibronectin (oncFN) and normal fibronectin (norFN) in colorectal cancer specimens was examined to investigate the correlation between fibronectin localization and histologic grade, liver metastasis, and prognosis.
METHODS: Immunohistochemical staining of oncFN and norFN was performed on 99 primary lesions and 12 liver metastases of colorectal cancer. The expression of norFN and oncFN was evaluated by grading the intensity of staining as negative, positive, or strongly positive.
RESULTS: Positive staining for oncFN correlated positively with increasing stage. The rate of strongly positive staining for oncFN was 53% for primary lesions with liver metastasis, significantly higher than the oncFN-positive rate of 13% for metastasis free cases (P < 0.05). Liver lesions had an oncFN-positive rate of 92%. The postoperative 5-year survival rate for 51 cases classified as Dukes Stage C was 77.8% for oncFN-negative cases, 36.5% for oncFN-positive cases, and 22.2% for oncFN-strongly positive cases; these rates were significantly different (P < 0.01). Conversely, there was no correlation between norFN and any clinical variable.
CONCLUSION: Expression of oncFN is correlated with a poor prognosis of Dukes C colorectal cancer and may serve as a useful postoperative prognostic sign.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773930     DOI: 10.1002/1097-0142(19950615)75:12<2802::aid-cncr2820751204>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 2.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

3.  Peptide targeted high-resolution molecular imaging of prostate cancer with MRI.

Authors:  Xueming Wu; Guanping Yu; Daniel Lindner; Susann M Brady-Kalnay; Qi Zhang; Zheng-Rong Lu
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-07-15

4.  Targeting Fibronectin for Cancer Imaging and Therapy.

Authors:  Zheng Han; Zheng-Rong Lu
Journal:  J Mater Chem B       Date:  2016-12-01       Impact factor: 6.331

Review 5.  Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects.

Authors:  H Kosmehl; A Berndt; D Katenkamp
Journal:  Virchows Arch       Date:  1996-12       Impact factor: 4.064

6.  Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.

Authors:  Zheng Han; Yajuan Li; Sarah Roelle; Zhuxian Zhou; Yuchi Liu; Rob Sabatelle; Aidan DeSanto; Xin Yu; Hui Zhu; Cristina Magi-Galluzzi; Zheng-Rong Lu
Journal:  Bioconjug Chem       Date:  2017-03-09       Impact factor: 4.774

7.  Magnetic resonance molecular imaging for non-invasive precision cancer diagnosis.

Authors:  Zheng-Rong Lu
Journal:  Curr Opin Biomed Eng       Date:  2017-11-16

8.  Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis.

Authors:  Sophie Astrof; Denise Crowley; Elizabeth L George; Tomohiko Fukuda; Kiyotoshi Sekiguchi; Douglas Hanahan; Richard O Hynes
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

9.  Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.

Authors:  Shanna A Arnold; Holli A Loomans; Tatiana Ketova; Claudia D Andl; Peter E Clark; Andries Zijlstra
Journal:  Clin Exp Metastasis       Date:  2015-10-11       Impact factor: 5.150

10.  Synthesis and Assessment of Peptide Gd-DOTA Conjugates Targeting Extradomain B Fibronectin for Magnetic Resonance Molecular Imaging of Prostate Cancer.

Authors:  Yajuan Li; Zheng Han; Sarah Roelle; Aidan DeSanto; Rob Sabatelle; Rebecca Schur; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2017-10-25       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.